For weight management, Wegovy (semaglutide) and Saxenda (liraglutide) are licensed for adults with a body mass index (BMI) of 30 kg/m or greater, or 27 kg/m or greater with weight-related comorbidities
It may also provide a range of other health-supporting benefits , aiding the bodys daily functioning
They are very beneficial for managing diabetes and weight loss because they act by decreasing hunger, slowing stomach emptying, and increasing insulin secretion
As research continues to unfold, the potential applications of tirzepatide may expand, offering hope for even broader patient populations in the future
[Google Scholar] 108.Maharjan R, Lim DS, Baik HJ, Park HE, Kim MS, Kim KH, et al
Is Ozempic for depression